Our mission is to improve the lives of patients experiencing serious, life-threatening diseases by the discovery, development and delivery of innovative therapies. Our lead therapy, Zorblisa™, is a proprietary topical therapy being developed for the treatment of patients with Epidermolysis Bullosa (EB).
Company Details
- Employees
- 6
- Address
- 465 W Coleman Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Rare Disease.
- HQ
- Mount Pleasant, South Carolina
Paradigm Therapeutics, Inc. Questions
Paradigm Therapeutics, Inc.'s website is http://www.paradigmtherapeutics.com
Paradigm Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/paradigm-therapeutics-inc
Paradigm Therapeutics, Inc. has
6 employees.
View email and phone details for 6
employees at Paradigm Therapeutics, Inc..
Paradigm Therapeutics, Inc.'s industry is
Biotechnology Research
Paradigm Therapeutics, Inc.'s top competitors are
Khartis Therapeutics, Inc.,
Trailhead Biosystems,
Axiom Bio,
Paq Therapeutics,
Newlimit,
Stately Bio,
Crinetics Pharmaceuticals,
Nuevocor,
Solabia Group,
Qbdvision.
Paradigm Therapeutics, Inc.'s categories are Biotechnology Research
